Header cover image

Spanish (IBEX) Healthcare Sector Analysis

UpdatedJan 22, 2022
DataAggregated Company Financials
Companies14
  • 7D-2.1%
  • 3M-12.1%
  • 1Y-18.3%
  • YTD-3.0%

Over the last 7 days, the Healthcare industry has risen 1.8%, driven by gains from Almirall of 1.8%. However, the industry is down 19% over the past year.

Sector Valuation and Performance

Has the Spanish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 22 Jan 2022€19.1b€7.9b€932.5m17x
Mon, 20 Dec 2021€19.0b€7.8b€931.2m16.9x
Wed, 17 Nov 2021€19.8b€7.8b€911.9m18.7x
Fri, 15 Oct 2021€21.7b€7.8b€912.6m19.3x
Sun, 12 Sep 2021€22.0b€7.8b€912.6m18.2x
Tue, 10 Aug 2021€22.2b€7.8b€912.6m18.3x
Mon, 03 May 2021€22.8b€7.7b€876.2m21.4x
Thu, 04 Feb 2021€22.9b€7.8b€977.0m23.4x
Sun, 08 Nov 2020€21.1b€7.9b€1.0b14.5x
Sat, 01 Aug 2020€21.6b€7.8b€910.8m18.2x
Tue, 05 May 2020€24.8b€7.7b€1.0b16.8x
Fri, 07 Feb 2020€24.3b€7.3b€854.5m21.8x
Thu, 31 Oct 2019€23.8b€7.1b€747.4m23.9x
Sun, 04 Aug 2019€24.0b€6.9b€758.9m20.2x
Wed, 08 May 2019€20.6b€6.6b€734.9m20.7x
Sat, 09 Feb 2019€19.6b€6.5b€742.3m21.5x
PE Ratio

21.5x

Total Market Cap: €19.6bTotal Earnings: €742.3mTotal Revenue: €6.5b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 19.7x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 7.9% per year over the last three years, and revenues for these companies have grown 6.4% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare sector?

Medical Equipment2.10%
Healthcare Services-0.58%
Pharma-2.16%
Biotech-2.35%
Life Sciences-6.35%

Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 30.6x. This is likely because analysts are expecting annual earnings growth of 21%, which is higher than its past year's earnings growth of 4.7% per year. Meanwhile, investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 190x.

Forecasted Growth: Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 111% over the next 5 years. Meanwhile, the Biotech industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALM Almirall€10.921.8%
+€34.2m
-5.4%PS2.4x
PRM Prim€14.552.1%
+€5.2m
51.9%PE18.3x
ORY Oryzon Genomics€3.121.5%
+€2.4m
-17.7%PS16.9x
PHM Pharma Mar€55.880.1%
+€1.4m
-35.4%PE16.6x
ADL ADL Bionatur Solutions€0.472.4%
+€501.7k
-32.6%PS7.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GRF

€16.62

Grifols

7D

-2.7%

1Y

-32.5%

PRM

€14.55

Prim

7D

2.1%

1Y

51.9%